Cardiopulmonary Corp: FDA Final Rule – Active Patient Monitoring or Medical Device Alarm Management requires more than an MDDS

Bernoulli (under company name Cardiopulmonary Corp.) received additional FDA 510(k) Class II clearance

CPC’s philosophy has always been to ensure that its Bernoulli® software is fully cleared by the FDA as a medical device under Class II for the intended use of active patient monitoring, and not just limited to data transfers to an EMR.